Contineum Therapeutics, Inc.
CTNM
$11.43
-$0.10-0.87%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 19.13M | 18.27M | 17.69M | 16.73M | 15.68M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 66.85M | 68.06M | 67.99M | 66.03M | 59.08M |
| Operating Income | -66.85M | -68.06M | -67.99M | -66.03M | -59.08M |
| Income Before Tax | -58.44M | -59.98M | -59.39M | -56.86M | -49.83M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -58.44 | -59.98 | -59.39 | -56.86 | -49.83 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -58.44M | -59.98M | -59.39M | -56.86M | -49.83M |
| EBIT | -66.85M | -68.06M | -67.99M | -66.03M | -59.08M |
| EBITDA | -66.53M | -67.74M | -67.68M | -65.74M | -58.80M |
| EPS Basic | -1.95 | -2.18 | -2.26 | -2.20 | -1.97 |
| Normalized Basic EPS | -1.22 | -1.36 | -1.41 | -1.38 | -1.23 |
| EPS Diluted | -1.95 | -2.18 | -2.26 | -2.20 | -1.97 |
| Normalized Diluted EPS | -1.22 | -1.36 | -1.41 | -1.38 | -1.23 |
| Average Basic Shares Outstanding | 122.21M | 110.74M | 105.70M | 103.31M | 100.77M |
| Average Diluted Shares Outstanding | 122.21M | 110.74M | 105.70M | 103.31M | 100.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |